Brief: Onxeo gets USPTO notice of allowance for AsiDNATM Patent

Valerio Therapeutics SA

04/07/2016 07:01

July 4 (Reuters) - Onxeo SA  C4X.PA : 
    * Onxeo receives USPTO notice of allowance for key AsiDNATM 
patent, extending IP protection in the US until 2031 
    * Products, including AsiDNA (signal interfering DNA), 
protected until 2031 with potential extension to 2036 
    * Onxeo's intellectual property for DNA repair signal 
interfering technology and products protected by 8 patent 
families worldwide 
    * Allowed patent has a term expiring in mid-2031, before a 
possible patent term adjustment (PTA) 
    * Term could be further extended to 2036 through patent term 
extension (PTE) 
 
Source text for Eikon:  ID:nBw2WkhP2a  
Further company coverage:  C4X.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))